MKLN1 and hepatocellular carcinoma: Recent studies have shown that MKLN1-AS is overexpressed in HCC, and that its upregulation can serve as a marker of adverse prognosis.[28,29] MKLN1-AS can enhance the expression of hepatoma-derived growth factor by functioning as a competitive endogenous RNA for miR-654-3p, which promotes deterioration of HCC.